BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, b‐AP15 induced downregulation of anti‐apoptosis proteins, including Bcl‐2, Mcl‐1, and Bcl‐xl in BCR‐ABLWT and BCR‐ABLT315I CML cells (Figure 2F).